![Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond - ScienceDirect Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1044579X20300493-gr1.jpg)
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond - ScienceDirect
![en]HER2 Therapies for Patients with mCRC[:fr]Les thérapies HER2 pour les patients atteints de mCCR[:] - Colorectal Cancer Canada en]HER2 Therapies for Patients with mCRC[:fr]Les thérapies HER2 pour les patients atteints de mCCR[:] - Colorectal Cancer Canada](https://www.colorectalcancercanada.com/wp-content/uploads/2023/08/her2receptor.png)
en]HER2 Therapies for Patients with mCRC[:fr]Les thérapies HER2 pour les patients atteints de mCCR[:] - Colorectal Cancer Canada
![Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors | Scientific Reports Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep41921/MediaObjects/41598_2017_Article_BFsrep41921_Fig7_HTML.jpg)
Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors | Scientific Reports
![Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancer | Investigational New Drugs Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancer | Investigational New Drugs](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10637-008-9155-y/MediaObjects/10637_2008_9155_Fig1_HTML.gif)
Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancer | Investigational New Drugs
![Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-44643-z/MediaObjects/41598_2019_44643_Fig1_HTML.png)
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports
![Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer | Clinical and Translational Oncology Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer | Clinical and Translational Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12094-019-02213-9/MediaObjects/12094_2019_2213_Fig1_HTML.png)
Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer | Clinical and Translational Oncology
![Breast cancers with EGFR and HER2 co‑amplification favor distant metastasis and poor clinical outcome Breast cancers with EGFR and HER2 co‑amplification favor distant metastasis and poor clinical outcome](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-6562-g01.jpg)
Breast cancers with EGFR and HER2 co‑amplification favor distant metastasis and poor clinical outcome
![Diagnostic de l'amplification du gène HER2 dans les cancers du sein: Le point de vue génétique - ScienceDirect Diagnostic de l'amplification du gène HER2 dans les cancers du sein: Le point de vue génétique - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0369811408000552-gr1.jpg)
Diagnostic de l'amplification du gène HER2 dans les cancers du sein: Le point de vue génétique - ScienceDirect
![Frontiers | HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies Frontiers | HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies](https://www.frontiersin.org/files/Articles/860313/fonc-12-860313-HTML/image_m/fonc-12-860313-g001.jpg)
Frontiers | HER2-Altered Non-Small Cell Lung Cancer: Biology, Clinicopathologic Features, and Emerging Therapies
![HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry | Cancer Cell International | Full Text HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry | Cancer Cell International | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12935-022-02761-1/MediaObjects/12935_2022_2761_Fig2_HTML.png)
HER2 amplification by next-generation sequencing to identify HER2-positive invasive breast cancer with negative HER2 immunohistochemistry | Cancer Cell International | Full Text
![Transcriptional coactivator MED1 in the interface of anti-estrogen and anti- HER2 therapeutic resistance Transcriptional coactivator MED1 in the interface of anti-estrogen and anti- HER2 therapeutic resistance](https://image.oaes.cc/23963ef2-37db-4c3c-abb4-fa0f268930a7/4752.fig.1.jpg)
Transcriptional coactivator MED1 in the interface of anti-estrogen and anti- HER2 therapeutic resistance
![IJMS | Free Full-Text | Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization IJMS | Free Full-Text | Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization](https://pub.mdpi-res.com/ijms/ijms-13-05519/article_deploy/html/images/ijms-13-05519f1.png?1403144182)